key: cord-0928286-kyk8pi64
authors: Badary, Osama A; Hamza, Marwa S; Tikamdas, Rajiv
title: Thymoquinone: A Promising Natural Compound with Potential Benefits for COVID-19 Prevention and Cure
date: 2021-05-03
journal: Drug Des Devel Ther
DOI: 10.2147/dddt.s308863
sha: 1eb29979e55b97fb6a928e903d22210f6aeb0f1c
doc_id: 928286
cord_uid: kyk8pi64

COVID-19 has caused a major global health crisis, as excessive inflammation, oxidation, and exaggerated immune response in some sufferers can lead to a condition known as cytokine storm, which may progress to acute respiratory distress syndrome (ARDs), which can be fatal. So far, few effective drugs have emerged to assist in the treatment of patients with COVID-19, though some herbal medicine candidates may assist in the fight against COVID-19 deaths. Thymoquinone (TQ), the main active ingredient of black seed oil, possesses antioxidant, anti-inflammatory, antiviral, antimicrobial, immunomodulatory and anticoagulant activities. TQ also increases the activity and number of cytokine suppressors, lymphocytes, natural killer cells, and macrophages, and it has demonstrated antiviral potential against a number of viruses, including murine cytomegalovirus, Epstein-Barr virus, hepatitis C virus, human immunodeficiency virus, and other coronaviruses. Recently, TQ has demonstrated notable antiviral activity against a SARSCoV-2 strain isolated from Egyptian patients and, interestingly, molecular docking studies have also shown that TQ could potentially inhibit COVID-19 development through binding to the receptor-binding domain on the spike and envelope proteins of SARS-CoV-2, which may hinder virus entry into the host cell and inhibit its ion channel and pore forming activity. Other studies have shown that TQ may have an inhibitory effect on SARS CoV2 proteases, which could diminish viral replication, and it has also demonstrated good antagonism to angiotensin-converting enzyme 2 receptors, allowing it to interfere with virus uptake into the host cell. Several studies have also noted its potential protective capability against numerous chronic diseases and conditions, including diabetes, hypertension, dyslipidemia, asthma, renal dysfunction and malignancy. TQ has recently been tested in clinical trials for the treatment of several different diseases, and this review thus aims to highlight the potential therapeutic effects of TQ in the context of the COVID-19 pandemic.

The novel coronavirus that causes COVID-19 was first discovered in 2019 in Wuhan, China. It has since spread globally, resulting in a worldwide pandemic. COVID-19 is an infectious disease that causes severe acute respiratory syndrome, leading to the virus causing it to be formally named SARS-CoV-2. Comorbidities such as chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients, 1 

Although researchers worldwide have worked exhaustively to find a solution, as yet, no entirely adequate therapy for COVID-19 has emerged. Alternative approaches must thus be subject to comprehensive attention, similar to the strategy used in the initial repurposing of conventional therapeutics. An example of such alternative therapy is found in the application of vitamin D, which has been suggested to help reduce the effect of the pandemic on maternal and child health. 10 Other speculative suggestions include the idea that vitamin C could help with COVID-19-related symptoms, 11 or that honey may have a positive impact on COVID-19 recovery. 12 Pharmacological intervention using natural products is considered another example of alternative medicine. 13 In the past, herbal medicine has played an important role in managing infectious disease, and a range of herbal medicinal studies on the treatment of a previous SARS coronavirus (SARS-CoV), have provided clinical evidence that herbal medicines have some advantageous effects with regard to the treatment and prevention of epidemics, with several significant results. 14 There is also clinical evidence that the use of herbal medicines can have positive consequences in certain COVID-19 treatments. 15, 16 One systematic review has shown significant impacts on efficacy and improvement of symptoms on combining herbal medicine with Western medicine in the treatment of COVID-19, suggesting that herbal medicine does have a potential role to play in COVID-19 treatment. Further clinical trials are, however, necessary to further confirm the efficacy, and any adverse effects, of herbal medicine as part of COVID-19 treatment. 17 Several edible plants are known to act as natural antiviral agents, and these may have the potential to be developed into a COVID-19 nutraceutical. Such a development may offer a supplementary treatment to help people cope with this highly infectious disease and thus protect the global population against the current pandemic. 18 In terms of daily diet, herbal preparations with immunomodulatory actions may offer prophylactic therapy to prevent infection and to help contain diseases within communities, as well as encouraging faster post-infection healing. 18 Natural Therapeutic Approaches Some reports have emerged of the beneficial effects of certain traditional herbal medicines with regard to COVID-19. Examples include Ginseng (Panax ginseng), which has a modulatory effect on human immune cells; 19 ginger (Zingiber officinale), which has anti-apoptotic, antiinflammatory, anti-tumor activities, anti-hyperglycemic, antioxidant, and analgesic properties; 20 garlic (Allium sativum), which stimulates the immune system; 21 and Echinacea extract (Echinacea purpurea (L.) Moench), which has antimicrobial and antioxidant activities. 22 Other herbal phyto-constituents have been reported to be effective in reducing infectious conditions, including triterpene glycosides isolated from Heteromorpha 23 and extracts from Artemisia annua, Lycoris radiata, Pyrrosia lingua and Lindera aggregate, 17,24 while natural inhibitors such as the nsP13 helicase and 3CL protease have been identified, along with myricetin, scutellarein, and phenolic compounds from Isatis indigotica and Torreya nucifera, to be operative against SARS-CoV enzymes. 25 Nigella sativa: An Overview Nigella sativa (Black seed), from the family Ranunculaceae, have been found in several ancient sites, including Tutankhamun's tomb. The Persian physician Avicenna, regarded as the father of early modern medicine, described the plant in his Canon of Medicine as offering a treatment for shortness of breath, 32 which frequently accompanies pathological conditions such as asthma and pneumonia. Volatile oils and alkaloids are generally associated with biological activity, and the volatile oils of these seeds contain nigellone, thymoquinone (TQ), thymohydroquinone, dithymoquinone, thymol, carvacrol, α and β-pinene, d-limonene, d-citronellol, p-cymene, carvacrol, t-anethole, 4-terpineol and longifolene. 33,34 Nigella sativa seeds thus offer a natural product with multiple potential pharmacological activities including antidiabetic, anticancer, immunomodulatory, analgesic, antimicrobial, anti-inflammatory, bronchodilator, renal and gastro-protective, and antioxidant properties. 35, 36 Thymoquinone Thymoquinone (2-Isopropyl-5-methylbenzo-1, 4-quinone) is the main active ingredient of the volatile oil of black seed ( Figure 1 ). It was first extracted by El-Dakhakhny, 37 and amongst the various different active constituents reported so far, TQ remains the major bioactive principle due to its range of therapeutic benefits including antioxidant, 38 antiinflammatory, 39 anti-cancer, 40 antibacterial, 41 antifungal activity, 42 and anticonvulsant activity. 43 Furthermore, a more specific effect of the antiviral activity of TQ and black seed fixed oil against murine cytomegalovirus infection model has been reported. 44, 45 TQ may thus offer integral complementary support in conditions of uncertain core basic needs during COVID-19 treatment. However, the question of whether TQ might act as a distinct therapeutic drug for the control and/or treatment of COVID-19 still remains to be investigated.

This review aims to focus on the potentially beneficial roles of TQ against COVID-19 pathophysiology in the context of antioxidant, anti-inflammatory, immunomodulatory, epigenetic modulation, antiviral activity, docking studies on anti-COVID-19 activity, antibacterial and anticoagulant effects for the treatment of COVID-19.

N sativa, due to its wide range of bioactive components such as TQ and nigellimine, could offer a range of benefits for treating COVID-19, such as blocking the introduction of the virus to pneumocytes; providing ionophores to improve zinc intake, thereby improving the host immune response to SARS-CoV-2; and preventing the virus from replicating. 29 TQ is the main bioactive principle in N Sativa, and this has been found to confer a range of therapeutic advantages 34 including antioxidant, 38 anti-inflammatory, 39, 46 anticancer, 40 antibacterial, 41 antifungal, 42 anticoagulant, 47 anti-sepsis, 48 and anticonvulsant activity. 43 N Sativa seeds have also demonstrated immunomodulatory effects, 49, 50 while several studies suggest that N Sativa seeds have some antiviral effects. 44, 51, 52 In addition to its immunomodulatory and antioxidant properties, however, N Sativa and its active constituents have also been noted to provide anti-ischemic effects in several organs, including the brain, kidney, heart, liver, and intestines. 53 Such evidence strongly suggests that N. sativa seeds and their active constituents may have significant therapeutic potential against COVID-19 and its complications 13,54 ( Figure 2 ).

Reactive oxygen species (ROS) are formed during normal cellular respiration and as a reaction to xenobiotics. 55 They are highly reactive, and thus may harm and change the functions of various cell components, such as lipids, proteins, nucleic acids, and carbohydrates. 56 Oxidative stress occurs due to imbalance between oxidants and antioxidants, 57 and it is a crucial factor in pathogenesis of many diseases 58 such as diabetes, 59 inflammation, 60 cardiovascular diseases, 61 cancer, 62 and advanced age. 63 A major factor in the excessive immune response seen in some COVID-19 infections may thus be the overwhelming of the antioxidative defense mechanism and the resulting oxidative damage. 55 Antioxidant properties require high radical-scavenging capabilities, and this is one of the essential characteristic functions of TQ. TQ works by activating the enzymes that protect cells from cellular damage caused by oxidative stress. Several studies have shown that TQ does this by increasing the expression of mRNA and stimulating various cytoprotective antioxidant enzymes, including catalases, superoxide dismutase, glutathione reductase, and glutathione-S-transferase. 64-68 TQ thus offers protection against glucose or methylglyoxal induced loss of superoxide dismutase activity and fragmentation or crosslinking. 69 

While the rapid spread of COVID-19 is concerning, the inflammatory response of the host is an important determinant of the outcome and severity of any infection. 70 A cytokine storm represents cytokine overproduction, seen in the most severe cases of COVID-19, a process which includes T cell depletion, pulmonary disease and damage to the lungs. 71 Granulocytosis can also lead to strong superoxide explosion, 72 the formation of reactive oxygen species (ROS) 73 and further production of proinflammatory cytokines. 74 The background of antiinflammatory therapy complementing antiviral therapy must thus be understood in order to manage such symptoms in COVID-19, as treatment should aim to control inflammation without affecting the host's ability to respond adaptively to the virus. The nuclear factor erythroid 2 (NFE2)-related factor 2 (Nrf2) can resist oxidative stress, 75 and this is always dysregulated in disease states, such as diabetes, liver disease, and inflammatory bowel diseases, 76 as well as in severe aging. 77 Any such conditions are thus risk factors for COVID-19induced ARDS. 78 Activation of Nrf2 has also been shown to be involved in preserving lung architecture in reactions to inflammatory syndrome, as well as having some therapeutic effects in various lung disorders, including respiratory infections and ARDS. 79 Furthermore, Nrf2 is responsible for the transcription of certain macrophage-specific genes involved in the tissue repair that grant protection from viral infections, 80 as well as restoring redox homeostasis, which protects against oxidative stress by upregulating thioredoxin reductase, glutathione, peroxiredoxin, and NADPH. 81 It has been reported that TQ decreases levels of various proinflammatory mediators, such as IL-1β, IL-6, TNFα, IFNβ, and PGE 66 in rats, as well as preventing pulmonary inflammation and improving the resistance of airways to damage induced by diesel exhaust particles. TQ also decreases blood leukocyte and plasma IL-6 levels. 82 In a mouse model of allergic asthma, TQ reduced lung eosinophils, increased Th2 cytokines, and decreased mucusproducing goblet cells. 46 TQ also inhibits inducible synthase nitric oxide (iNOS) and transforming growth factor-β1 in asthmatic murine experimental models. [83] [84] [85] The experimental evidence suggests that TQ inhibits cyclooxygenase (COX) and lipoxygenase enzymes, preventing the generation of eicosanoids. 86 TQ decreases the synthesis of LTs 87 and inhibits prostaglandin and thromboxane synthesis by decreasing COX2 expression, achieved by upregulating IL-1 receptor-associated kinase 1 (IRAK1). 88 IRAK1-mediated signal inhibitors also downregulate NF-κB and activator protein 1/AP1 transcriptional activities which are required to activate the COX-2 expression, 88 and TQ further downregulates the expression of many other inflammatory cytokines and signals mediators, including interleukin IL-1, IL-6, TNFα, and iNOS. 88 These mediators can cause alveolar macrophages and neutrophils to create more damage by increasing pulmonary vascular permeability, releasing oxygen radicals and proteolytic enzymes. 89 The antioxidant activity of TQ can also help in minimizing cell inflammation, while its ROS generation plays an important role in the synthesis of arachidonic acid based on the activation and/or expression of the basic upstream signaling molecules protein kinase B and NF-κB. 90 Immunomodulatory Effect TQ has several major immunomodulatory effects due to the crosslink between inflammatory and immunomodulatory pathways. TQ could thus potentially suppress inflammation-induced immunosuppression based on its negative effects on proinflammatory eicosanoid synthesis and mediated gene expression in NF-κB. 91 TQ can thus modulate many aspects of cellular and humoral immunity by inhibiting the function and expression of various inflammatory cytokines and their effector molecules. 92 TQ modulates cell immune responses, including dendritic cell maturity, NK-cells cytotoxicity, phagocytic involvement, chemotaxis, and the activation of T-cells. It also tends to have a context-relating effect on particular cell immune responses: for example, TQ prevents the maturation of lipopolysaccharide-induced dendritic cells by blunting the expression of IL-10, IL-12 and TNFα with enhancement of caspase 3/8 and increasing annexin V binding. 93 TQ also improves the survival of CD8 antigen-specific T cells and improves the sustained expression of L-selectin, which may have an important effect on adoptive T cell therapy. 94 

Various epigenetic pathways are involved in COVID-19 infection, and these pathways may thus be therapeutically utilized. 95 Possible targets for host immune response include epigenetic enzymes. 96, 97 The aberrant genetic expression and protein function that characterize COVID-19 are caused by genetic and epigenetic changes, and natural compounds can target and regulate genetic expression, directly or indirectly, based on their interference with genetic and epigenetic mechanisms. 98-100 TQ is thus a promising molecule because it modulates epigenetic properties such as histone acetylation and deacetylation as well as DNA methylation and demethylation. 101, 102 In addition, TQ plays a role in activating and deactivating noncoding RNA, acting as a potent apoptosis-induced enzyme that causes histone acetylation and deacetylation. [103] [104] [105] Endogenous miRNA activity has been studied in the field of viral replication for several complex virus mechanisms. 106 It has thus been shown that miR34a has an effect on the inactivation of epithelial-mesenchymal transition-transcription factors (EMT-TFs), and epithelial-mesenchymal transition is known to play a crucial role in organ fibrosis and epithelial cell malignancy. 107 A promising therapeutic approach against COVID-19 thus stems from the idea of inactivating EMT-TFs using miR34a, 108 as a previous study showed that TQ may act as an enhancer of miR34a activity. 109 miR146a is another miR involved in the process of inflammatory cytokine inhibition, which acts via the NF-κB pathway. 110 It functions as a negative regulator for NF-κB, and it is a wellrecognized transcript factor for the IL-6 gene. 111 miR-146a-5p transcription is also regulated by NF-κB, 112 and patients with COVID-19 have been shown to have higher levels of IL-6 and lower levels of miR-146a-5p than average, suggesting imbalances in the physiological axis of IL-6/miR-146a-5p in the pathogenesis of COVID-19 infections. 113 TQ treatment, however, controls miR146a expression and can therefore reduce inflammatory reactions by interfering with NF-kB. 114 

Several studies support the potential antiviral activity of TQ against various viral infections, which is mainly attributed to its multiple beneficial effects, such as antioxidant, anti-inflammatory, and immunomodulatory effects in addition to possible direct viral eradication. 115, 116 The antiviral effect of Nigella sativa oil, including its major active component TQ, was demonstrated in a murine cytomegalovirus (MCMV) model; this showed that Nigella sativa significantly reduced the liver and spleen viral loads, which coincided with enhanced IFN-γ production and increased CD4 (+) T cell response. 44 TQ has also been shown to significantly inhibit Epstein-Barr virus (EBV) replication in EBV-infected B cells, 117 while Nigella sativa has been shown to exhibit antiviral activity against the hepatitis C virus (HCV), as evidenced by reduced viral load and improved liver function in HCV patients who received Nigella sativa at 450 mg, three times a day for 51 This effect is also supported by observations of the selective inhibition of HCV virus replication by alpha-zam, a Nigella sativa seed formulation. 118 Nigella sativa has also been suggested to be effective in controlling human immunodeficiency virus (HIV) infection, with one study reporting that treatment of HIV patients with Nigella sativa for six months resulted in sustained sero-reversion with a significant reduction in viral load and CD4 count elevation. 52 Nigella sativa extract containing TQ has also, more specifically, been reported to decrease viral replication and loads in cells infected with some coronaviruses. 119 Interestingly, one in vitro study demonstrated that TQ showed significant antiviral activity against a SARSCoV-2 strain isolated from Egyptian patients, 120 possibly through blocking the entry of the virus into the cells. 121 Overall, the existing studies highlight the immense potential of TQ as an effective antiviral agent against COVID-19, a premise which is highly supported by the molecular docking studies examining TQ's effects against various virus and host cell targets, which are discussed in more detail in the following section.

Molecular docking is a promising in silico method that may be used to screen various compounds for their antiviral potential by testing the binding affinities of the compounds against different viral or host cell receptor proteins. The molecular targets of SARS-CoV-2 include various viral proteins involved in viral entry, such as spike proteins, and replication, such as viral proteases. 122 In addition, host cell targets, such as angiotensin-converting enzyme 2 (ACE2) receptor and cell surface heat shock protein (HSPA5), which are involved in viral entry, may also offer potential therapeutic targets. 122 Molecular docking studies have already shown that TQ could potentially inhibit COVID-19 by binding to the receptor-binding domain on the spike protein of SARS-CoV-2, which would hinder virus entry into the host cell. 123 Additionally, it may bind to the SARS-CoV-2 envelope protein and inhibit its ion channel and pore formation activity. 124 Other studies have shown that TQ might display inhibitory action against the SARS CoV2 protease, which would halt viral replication. 120, [125] [126] [127] TQ has also demonstrated a good affinity against ACE2 receptors, which allows it to interfere with virus uptake into the host cell. 121, 127 Molecular dynamics simulations have shown that TQ can interfere with the attachment of SARS-CoV-2 to host cells by binding to a cell surface, HSPA5, which is recognized by the viral spike protein and upregulated upon viral infection. 128, 129 These in silico studies indicate a multi-targeted potential for TQ against COVID-19, and thus pave the way for further investigation of such anti-COVID-19 potential through invitro and in-vivo studies that may better support translation into clinical practice.

COVID-19 may also be associated with serious secondary bacterial infections, such as bacterial pneumonia, as well as nosocomial infections resulting from the prolonged hospitalization of critically ill patients, both of which significantly increase morbidity and mortality in COVID-19 patients. 130 Moreover, the intensive use of antibiotics in patients suffering from COVID-19 could result in the emergence of multidrug-resistant bacteria, which could further worsen COVID-19 adverse outcomes. 131 Interestingly, TQ exerts antibacterial activity against several Gram positive and Gram negative bacteria, including Staphylococcus aureus, Pseudomonas aeruginosa and Escherichia coli, which could be used to augment antibiotic effects. 41, 116, 132 Furthermore, TQ has demonstrated significant antimicrobial activity against anaerobic bacteria, specifically Clostridium difficile, 133 as well as clinical isolates of Mycobacterium tuberculosis, 134 alongside antibacterial and resistance modifying activities with regard to methicillin-resistant Staphylococcus aureus (MRSA) 135 and Listeria monocytogenes. 136 Nigella sativa was also seen to be significantly effective in eradicating Helicobacter pylori in patients with non-ulcer dyspepsia. 137 This suggests that TQ could play a significant role in the prevention and management of secondary bacterial infections in COVID-19 patients in addition to its potential value for modifying bacterial resistance and potentiating antibiotic actions.

Thrombotic complications have become a major problem in COVID-19 patients. Preliminary COVID-19 studies have shown that infected patients typically develop thrombocytopenia with higher D-dimer levels, while the rates of developing thrombocytopenia in patients with severe COVID-19 are even higher. 70 Viral infections often cause systemic inflammatory responses and interfere with the balance of procoagulants and anticoagulants, 138 and in severe or critically ill patients, large quantities of inflammatory mediators, hormones and immunoglobulin are released, leading to blood hypercoagulability. The level of interleukins, especially IL-6, IL-7, IL-2, granulocyte colony-=stimulating factor, monocyte chemoattractant protein-1, macrophage inflammatory proteins 1-alpha, and TNFα, has been similarly found to be increased in patients with COVID-19. 139 An earlier study found that coagulation factors VII, VIII, II, V, and X were significantly increased in COVID-19 patients. 140 TQ, however, interferes with blood clotting by directly decreasing factor Xa activity in the blood coagulation pathway and by down-regulating TNFα, a cytokine that plays a critical role in the link between inflammatory and thrombosis pathways. 47

The magnitude of COVID-19 infection is increased by a variety of comorbidities. TQ may thus also be helpful in patients infected with COVID-19 where it can relieve some comorbidity. 13 Serious COVID-19 complications include ARDS, pneumonia and multi-organ failure, and the risk of all of these is increased in patients with diabetes and cardiovascular diseases. 141,142 N. Sativa has been shown to reduce plasma glucose levels and control haemoglobin-A1c, 143 while intraperitoneal administration of TQ has been demonstrated to substantially decrease hyperglycemia in streptozotocin-induced diabetes in the rats. 144 One study reported that 7% of deaths in COVID-19 patients can be ascribed to circulatory failure in myocarditis, suggesting that cardiovascular disorders play an important role in determining final adverse outcomes. 145 TQ can also act centrally as an antihypertensive agent, as well as having a regulatory effect on platelet aggregation and blood clotting, 146, 147 and TQ protects the heart from injury induced by isoproterenol in rats. 148 It is also notable that autoimmune and autoinflammatory diseases, especially in children, may impact the severity of COVID-19 infection, with overlapping symptoms leading to pediatric inflammatory multisystem syndrome (PIMS) that includes Kawasaki-like diseases. 149, 150 This complex syndrome has been reported as "Kawa-COVID-19" because of the association with the symptoms of COVID-19 infection. 151, 152 In patients with Kawa-COVID-19, C-Reactive protein (CRP), IL-6, IL-8, and TNF-α were all significantly raised, 153 suggesting that Nigella sativa could play a beneficial role in controlling incidence of PIMS or Kawa-COVID-19 by regulating and modulating immune response and reducing the occurrence of proinflammatory cytokines IL-2, IL-4, IL-5, II-6, IL-12, and IL-13. 154

TQ can be used in combination with other therapeutic agents that may be usefully repurposed for the treatment of COVID-19, as well as alongside other supportive treatments. Given the multiple beneficial effects of TQ and its favorable safety profile, 155 the adjunct use of TQ with conventional therapeutic agents would have the dual benefit of attenuating druginduced toxicity and improving therapeutic effectiveness, which could in turn result in reducing the required effective dosage of concomitantly used drugs, thus further minimizing any adverse effects. The potential cardioprotective, 156 neuroprotective, 157 hepatoprotective, 158 nephroprotective, 159 and gastroprotective 160 effects of TQ may thus be employed in counteracting a range of drug-associated toxicities; 161 currently, various supportive treatments such as acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) render COVID-19 patients at increased risk of liver and kidney toxicity. 162, 163 TQ has been shown to counteract acetaminopheninduced hepatotoxicity 164, 165 as well as NSAIDsassociated nephrotoxicity and gastrointestinal side effects. 166 TQ can also act synergistically with corticosteroids to protect the lungs by mitigating the inflammatory response and resulting cytokine storm; this would allow the use of lower steroid doses, thus reducing the risk of potential adverse effects. 167, 168 TQ has further demonstrated significant protective effects against the renal toxicity associated with antibiotics, such as vancomycin used in COVID-19 patients with secondary bacterial respiratory infections. 169 TQ could also potentially counteract the toxic effects of various repurposed drugs, 170, 171 such as the cardiotoxicity risk associated with chloroquine and azithromycin 161, 172, 173 and the potential liver and kidney toxicities associated with antivirals such as remdesivir and lopinavir. 155 DovePress effects 160 against gastric ulceration, which is associated with the IL-6 antagonist, tocilizumab, 174 in addition to potentiating its anti-inflammatory effect. 175

The high hydrophobic and lipophilic characters of TQ lead to poor solubility, low bioavailability, and difficulty in formulation. 176 The various pharmacokinetics of TQ have been reported in detail, [177] [178] [179] and TQ has poor oral bioavailability based on its low aqueous solubility and dissolution rate. 180 Moreover, TQ shows rapid polyexponential decline following intravenous dosing, 178 as well as binding with bovine serum albumin and alpha-1 acid glycoprotein. [181] [182] [183] This poor solubility and limited bioavailability are the two main problems for developing TQ for clinical use, and several chemical derivatives and novel nanoformulations have thus been developed to improve the pharmacokinetic behaviors of TQ to increase bioavailability. 184,185 TQ has, for example, been successfully encapsulated into nanolipid carriers. [186] [187] [188] TQ in different dose ranges shows beneficial effects with negligible toxicity in animal models of different diseases. [156] [157] [158] [159] [189] [190] [191] [192] [193] [194] [195] TQ is a well-tolerated drug in rodents, and numerous studies have been done to determine the toxicological properties of TQ in vitro and in vivo. [196] [197] [198] Even mice treated with 0.03% TQ in their drinking water for three months showed no signs of toxicity. 196 Moreover, TQ has demonstrated a high safety profile in rats based on high doses using oral and intraperitoneal administration. 199, 200 TQ compounds are currently used in clinical trials for the treatment of various types of cancer and other diseases. 201, 202 In a Phase I safety and clinical activity study of TQ in patients with advanced refractory malignant disease, TQ was well tolerated at doses ranging from 75 mg/day to 2600 mg/day, with neither toxicities nor therapeutic responses reported. 203 This absence of side effects in humans is in agreement with the extremely low toxicity of oral TQ administration in experimental animals. 196

Despite the numerous molecular docking studies on potential anti-COVID-19 activity of TQ, experimental studies on the effects of TQ against COVID-19 and its associated complications remain limited. The multi-targeted beneficial effects of TQ and its favorable safety profile do, however, appear to warrant in-vivo investigations and clinical trials on its anti-COVID-19 potential to support the translation into clinical practice to treat COVID-19 patients either alone or in combination with other potential therapies. TQ could also provide the additional benefits of ameliorating comorbidities and attenuating certain drug-induced adverse effects, as well as improving the therapeutic effectiveness of some other therapies. Novel formulations of TQ nanoparticles may, however, be required to overcome the poor bioavailability and the pharmacokinetic limitation of this compound in terms of clinical use.

This article examined the concept that certain natural compounds may target the molecular mechanisms of COVID-19, as well as potentially assisting with overcoming the diverse health complications associated with the repeated use or withdrawal of conventional therapeutics. TQ, the main active ingredient of Black seed oil, is an easy, cost-effective natural source of anti-inflammatory, antioxidant, immune stimulant, antibacterial, anticoagulant, and antiviral properties. TQ use may thus be expected to improve COVID-19 comorbidities and to protect against certain antiviral drug-induced side effects and toxicities. TQ appears to be a promising therapeutic option for managing COVID-19 and its complications, and clinical trials in COVID-19 patients to examine the beneficial effects of TQ are thus highly recommended.

ACE, angiotensin-converting enzyme; ARDS, acute respiratory distress syndrome; COVID-19, coronavirus disease-2019; COX, cyclooxygenase; EBV, Epstein-Barr virus; EMT-TFs, epithelial-mesenchymal transition-transcription factors; HCV, hepatitis C virus; HIV, human immunodeficiency virus; HSP, heat shock protein; IL, interleukin; IRAK1, interleukin-1 receptor-associated kinase 1; MCMV, murine cytomegalovirus; Nrf2, the nuclear factor erythroid 2 (NFE2)-related factor 2; ROS, reactive oxygen species; SARS-CoV-2, severe acute respiratory syndrome; TQ, thymoquinone.

The authors report no conflicts of interest in this work. 

Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: a systemic review and meta-analysis

A review on therapeutic potential of Nigella sativa: a miracle herb

Studies on the Chemical Constitution of Egyptian Nigella Sativa L. Seeds. II1) the essential oil

Effect of thymoquinone, a constituent of Nigella sativa L., on ischemia-reperfusion in rat skeletal muscle

Anti-inflammatory effect of thymoquinone in a mouse model of allergic lung inflammation

Thymoquinone reduces mouse colon tumor cell invasion and inhibits tumor growth in murine colon cancer models

Antibacterial activity of thymoquinone and thymohydroquinone of Nigella sativa L. and their interaction with some antibiotics

American science efficacy of thymoquinone against vaginal candidiasis in prednisolone-induced immunosuppressed mice

Anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa seeds, in mice

Protective effect of black seed oil from Nigella sativa against murine cytomegalovirus infection

Natural therapeutic approach of Nigella sativa (Black seed) fixed oil in management of Sinusitis

Downregulation of leukotriene biosynthesis by thymoquinone attenuates airway inflammation in a mouse model of allergic asthma

Thymoquinone modulates blood coagulation in vitro via its effects on inflammatory and coagulation pathways

Thymoquinone reduces mortality and suppresses early acute inflammatory markers of sepsis in a mouse model

Nigella sativa: effect on human lymphocytes and polymorphonuclear leukocyte phagocytic activity

Immunomodulatory effect of Nigella sativa proteins fractionated by ion exchange chromatography

Effects of Nigella sativa on outcome of hepatitis C in Egypt

Nigella sativa concoction induced sustained seroreversion in HIV patient

A glance at black cumin (Nigella sativa) and its active constituent, thymoquinone, in ischemia: a review

Covid-19 and thymoquinone: connecting the dots

Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling

Oxidative stress and antioxidant defense

What is oxidative stress?

Oxidative stress, redox imbalance, and the aging process

Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia

New pathways for reactive oxygen species generation in inflammation and potential novel pharmacological targets

Oxidative stress in atherosclerosis

Reactive oxygen species: role in the development of cancer and various chronic conditions

Oxidative stress and aging

Cancer: thymoquinone antioxidant/pro-oxidant effect as potential anticancer remedy

The effect of Nigella sativa oil and metformin on male seminal parameters and testosterone in Wistar rats exposed to an obesogenic diet

Modulation of the oxidative stress and inflammatory cytokine response by thymoquinone in the collagen induced arthritis in Wistar rats

The role of thymoquinone as a potent antioxidant in ameliorating the neurotoxic effect of sodium arsenate in female rat

Thymoquinone is a potent superoxide anion scavenger

Protective effect of thymoquinone on glucose or methylglyoxal-induced glycation of superoxide dismutase

Clinical characteristics of Coronavirus Disease 2019 in China

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Neutrophils in viral infections: current concepts and caveats

Reactive oxygen species (ROS) as pleiotropic physiological signalling agents

Inhibition of NF-κB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival

Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway

Dysregulation of Nrf2/Keap1 redox pathway in diabetes affects multipotency of stromal cells

Redox regulation by NRF2 in aging and disease

Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus Disease 2019 pneumonia in Wuhan, China

Role of Nrf2 and its activators in respiratory diseases

Nrf2 induces IL-17D to mediate tumor and virus surveillance

Redox control of inflammation in macrophages

Contrasting actions of diesel exhaust particles on the pulmonary and cardiovascular systems and the effects of thymoquinone

Comparative evaluation of anti-inflammatory properties of thymoquinone and curcumin using an asthmatic murine model

Mast cell myositis: a new feature of allergic asthma?

Nitric oxide pathway as a potential therapeutic target in COVID-19

Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation

Inhibition of 5-lipoxygenase and leukotriene C4 synthase in human blood cells by thymoquinone

Thymoquinone: an IRAK1 inhibitor with in vivo and in vitro anti-inflammatory activities

Proinflammatory response of alveolar epithelial cells is enhanced by alveolar macrophage-produced TNF-alpha during pulmonary ischemia-reperfusion injury

The effect of reactive oxygen species on the synthesis of prostanoids from arachidonic acid

Immunomodulatory and anti-inflammatory action of Nigella sativa and thymoquinone: a comprehensive review

Effect of thymoquinone on mouse dendritic cells

Thymoquinone ameliorates the immunological and histological changes induced by exposure to imidacloprid insecticide

Management of epigenomic networks entailed in coronavirus infections and COVID-19

Epigenetic mechanisms regulating COVID-19 infection

Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies: a pan-cancer analysis

Epigenetic mechanisms in anti-cancer actions of bioactive food components-the implications in cancer prevention

DNA methylation-mediated nucleosome dynamics and oncogenic Ras signaling: insights from FAS, FAS ligand and RASSF1A

Epigenetic choreography of stem cells: the DNA demethylation episode of development

The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells

Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells

Insights into the molecular interactions of thymoquinone with histone deacetylase: evaluation of the therapeutic intervention potential against breast cancer. Article

SIRT1 phosphorylation by AMP-activated protein kinase regulates p53 acetylation

Role of deleted in breast cancer 1 (DBC1) protein in SIRT1 deacetylase activation induced by protein kinase A and AMP-activated Protein Kinase*

Viruses and miRNAs: more friends than foes

Epithelial and endothelial cell plasticity in chronic obstructive pulmonary disease (COPD)

Drug Design

Deregulated miRNA expression is associated with endothelial dysfunction in post-mortem lung biopsies of COVID-19 patients

MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion

Involvement of microRNA-146a in diabetic peripheral neuropathy through the regulation of inflammation

Myeloid cell-targeted miR-146a mimic inhibits NF-κB-driven inflammation and leukemia progression in vivo

Involvement of microRNA-146a in the inflammatory response of status epilepticus rats

Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients

Epigenetic role of thymoquinone: impact on cellular mechanism and cancer therapeutics

Thymoquinone: shield and sword against SARS-CoV-2. Precis Nanomed

Black cumin (Nigella sativa) and its constituent (thymoquinone): a review on antimicrobial effects

Thymoquinone efficiently inhibits the survival of EBV-infected B cells and alters EBV gene expression. Integr Cancer Ther

Selective inhibition of hepatitis C virus replication by alpha-zam, A Nigella sativa seed formulation

Anthemis hyalina (Ah) and Citrus sinensis (Cs) extracts on the replication of coronavirus and the expression of TRP genes family

In vitro: natural compounds (Thymol, Carvacrol, Hesperidine, and Thymoquinone) against Sars-Cov2 strain isolated from Egyptian patients

Computational and experimental studies reveal that thymoquinone blocks the entry of coronaviruses into in vitro cells

COVID-19: molecular targets, drug repurposing and new avenues for drug discovery

The revelation of various compounds found in Nigella sativa L. (Black Cumin) and their possibility to inhibit COVID-19 infection based on the molecular docking and physical properties

Molecular docking analysis of phytochemical thymoquinone as a therapeutic agent on SARS-Cov-2 envelope protein

Identification of compounds from Nigella Sativa as new potential inhibitors of 2019 Novel Coronavirus (Covid-19): Molecular Docking Study

In silico investigation of the SARS CoV2 protease with thymoquinone, the Major Constituent of Nigella Sativa

Djemel A In-silico identification of potent inhibitors of COVID-19 Main Protease (Mpro) and Angiotensin Converting Enzyme 2 (ACE2) from natural products: quercetin, hispidulin, and cirsimaritin exhibited better potential inhibition than hydroxy-chloroquine against COVID-19 main protease active site and ACE2

Natural products may interfere with SARS-CoV-2 attachment to the host cell

COVID-19 spike-host cell receptor GRP78 binding site prediction

Covid-19 induced superimposed bacterial infection

The unrecognized threat of secondary bacterial infections with COVID-19

Antibacterial activity of Thymoquinone, an active principle of Nigella sativa and its potency to prevent bacterial biofilm formation

An active principle of Nigella sativa L., thymoquinone, showing significant antimicrobial activity against anaerobic bacteria

In vitro antituberculous activity of thymoquinone, an active principle of Nigella sativa

In vitro profiling of antimethicillin-resistant Staphylococcus aureus activity of thymoquinone against selected type and clinical strains

Antibacterial and resistance modifying activities of Nigella sativa essential oil and its active compounds against listeria monocytogenes

Comparative study of Nigella Sativa and triple therapy in eradication of Helicobacter Pylori in patients with non-ulcer dyspepsia

Procoagulant activity during viral infections

Increased TNF-alpha-induced apoptosis in lymphocytes from aged humans: changes in TNF-alpha receptor expression and activation of caspases

Systemic inflammatory response syndrome is a major contributor to COVID-19-associated coagulopathy: insights from a Prospective

Effect of thymoquinone on acute kidney injury induced by sepsis in BALB/c mice

Clinical considerations for patients with diabetes in times of COVID-19 epidemic

Nigella sativa improves glycemic control and ameliorates oxidative stress in patients with type 2 diabetes mellitus: placebo controlled participant blinded clinical trial

Antihyperglycemic effect of thymoquinone and oleuropein, on streptozotocin-induced diabetes mellitus in experimental animals

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

The cardiovascular actions of the volatile oil of the black seed (Nigella sativa) in rats: elucidation of the mechanism of action

Hematological studies on black cumin oil from the seeds of Nigella sativa L

The effect of thymoquinone, an active component of Nigella sativa, on isoproterenol induced myocardial injury

Autoimmune and inflammatory diseases following COVID-19

An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study

Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort

Kawasaki-like multisystem inflammatory syndrome in children during the COVID-19 pandemic in Paris, France: prospective observational study

Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department

Medicinal benefits of Nigella sativa in bronchial asthma: a literature review

Therapeutic potential and pharmaceutical development of thymoquinone: a multitargeted molecule of natural origin

Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity

Thymoquinone protects against carbon tetrachloride hepatotoxicity in mice via an antioxidant mechanism

Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity

The protective effect of thymoquinone on ethanol-induced acute gastric damage in the rat

The protective role of thymoquinone against drugs toxicity: a review

Hepatotoxicity of paracetamol and related fatalities

Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective

Thymoquinone supplementation reverses acetaminophen-induced oxidative stress, nitric oxide production and energy decline in mice liver

Thymoquinone treatment against acetaminophen-induced hepatotoxicity in rats

Diclofenac induced gastrointestinal and renal toxicity is alleviated by thymoquinone treatment

A new agent for treatment of acute respiratory distress syndrome: thymoquinone. An experimental study in a rat model

Thymoquinone treatment modulates the Nrf2/HO-1 signaling pathway and abrogates the inflammatory response in an animal model of lung fibrosis

Protective effects of thymoquinone on vancomycin-induced nephrotoxicity in rats

COVID-19 and toxicity from potential treatments: panacea or poison

COVID-19: therapeutics and their toxicities

Thymoquinone protects against myocardial ischemic injury by mitigating oxidative stress and inflammation

The cardioprotective effect of thymoquinone on ischemia-reperfusion injury in isolated rat heart via regulation of apoptosis and autophagy

Bowel ulceration following tocilizumab administration in a COVID-19 patient

Drug Design

Thymoquinone increases the expression of neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NFκB pathway signaling targets in LPS/IFNγ -activated BV-2 microglia cells

Thymoquinone in liposomes: a study of loading efficiency and biological activity towards breast cancer

Highperformance liquid chromatography of thymoquinone in rabbit plasma and its application to pharmacokinetics

Pharmacokinetic plasma behaviors of intravenous and oral bioavailability of thymoquinone in a rabbit model

Effect of compromised liver function and acute kidney injury on the pharmacokinetics of thymoquinone in a rat model

Oral bioavailability enhancement and hepatoprotective effects of thymoquinone by self-nanoemulsifying drug delivery system

Thymoquinone, a potential therapeutic agent of Nigella sativa, binds to site I of human serum albumin

Impact of protein binding on the analytical detectability and anticancer activity of thymoquinone

Characterization of thymoquinone binding to human α1-acid glycoprotein

Thymoquinone hydrazone derivatives cause cell cycle arrest in p53-competent colorectal cancer cells

Enhancement of bioavailability and pharmacodynamic effects of thymoquinone via Nanostructured Lipid Carrier (NLC) formulation

Thymoquinone-loaded nanostructured lipid carrier exhibited cytotoxicity towards breast cancer cell lines (MDA-MB-231 and MCF-7) and cervical cancer cell lines (HeLa and SiHa)

Acute and subacute toxicity profiles of thymoquinone-loaded nanostructured lipid carrier in BALB/c mice

Protective roles of thymoquinone nanoformulations: potential nanonutraceuticals in human diseases

Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice

The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats

Effect of thymoquinone on hepatorenal dysfunction and alteration of CYP3A1 and spermidine/spermine N-1-acetyl-transferase gene expression induced by renal ischaemia-reperfusion in rats

Thymoquinone alleviates thioacetamide-induced hepatic fibrosis and inflammation by activating LKB1-AMPK signaling pathway in mice

Chemopreventive and therapeutic potentials of thymoquinone in HepG2 cells: mechanistic perspectives

Preclinical and clinical effects of Nigella sativa and its constituent, thymoquinone: a review

Protective effects of thymoquinone on D-galactose and aluminum chloride induced neurotoxicity in rats: biochemical, histological and behavioral changes

Acute and subchronic toxicity of thymoquinone in mice

Thymoquinone-induced suicidal erythrocyte death

In vitro toxicological properties of thymoquinone

Oral and intraperitoneal LD50 of thymoquinone, an active principle of Nigella sativa, in mice and rats

The effect of route of administration in thymoquinone toxicity in male and female rats

Review on Clinical Trials of Black Seed (Nigella sativa) and its Active Constituent

as an anticancer molecule: from basic research to clinical investigation

Phase I Safety and Clinical Activity Study of Thymoquinone in patients with advanced refractory malignant disease

Drug Design, Development and Therapy is an international, peerreviewed open-access journal that spans the spectrum of drug design and development through to clinical applications. Clinical outcomes, patient safety, and programs for the development and effective, safe, and sustained use of medicines are a feature of the journal, which has also been accepted for indexing on PubMed Central. The manuscript management system is completely online and includes a very quick and fair peer-review system, which is all easy to use. Visit http://www. dovepress.com/testimonials.php to read real quotes from published authors.